(IN BRIEF) EMA, together with the European Commission and the Heads of Medicines Agencies, has released the first report measuring progress toward the EU’s 2030 clinical trial targets. The report shows that 19 additional multinational clinical trials have been authorised … Read the full press release
Posted in Business, European Union, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Accelerating Clinical Trials in the EU, ACT EU, biotechnology, clinical research, clinical trial authorisation, clinical trial reform, clinical trial timelines, drug development, EMA, EMA and EU Authorities Advance Clinical Research Reforms Under 2030 Trial Strategy, EMA Highlights Early Progress in EU Efforts to Expand and Accelerate Clinical Trials, EU Biotech Act, EU clinical trials, EU Reports Early Progress Toward 2030 Clinical Trial Goals, European Commission, European Medicines Agency, European Union, FAST-EU, Heads of Medicines Agencies, Healthcare Innovation, healthcare policy, healthcare regulation, HMA, innovative medicines, life sciences, medical research, Medicine Development, multinational clinical trials, Patient Recruitment, pharmaceutical innovation, pharmaceutical sector, regulatory transparency, research investment
(IN BRIEF) The European Commission, EMA, and HMA have set new targets to strengthen Europe’s role in clinical research by authorising an additional 500 multinational clinical trials over five years and ensuring that two-thirds of studies begin patient recruitment within … Read the full press release
Posted in European Union, Government, Healthcare, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged ACT EU, Ana Zanoletty, clinical trial ecosystem, Clinical Trials Information System, Clinical Trials Regulation, COMBINE programme, Corinna Hartung, CTIS, CTR, CTR Collaborate, EMA, EMA and partners unveil new clinical trial benchmarks under ACT EU to enhance Europe’s competitiveness in medical research, EU healthcare, EU launches five-year plan to authorise 500 more multinational clinical trials and speed up patient recruitment timelines, Europe competitiveness, European Commission, Heads of Medicines Agencies, HMA, ICH E6 R3, innovative medicines, Marianne Lunzer, MedEthicsEU, medical research, multinational clinical trials, Patient Recruitment
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?